[HTML][HTML] COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection

S Beyerstedt, EB Casaro, ÉB Rangel - European journal of clinical …, 2021 - Springer
COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. Angiotensin-
converting enzyme 2 (ACE2) is not only an enzyme but also a functional receptor on cell …

[HTML][HTML] Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract

T Flerlage, DF Boyd, V Meliopoulos… - Nature Reviews …, 2021 - nature.com
Influenza viruses cause annual epidemics and occasional pandemics of respiratory tract
infections that produce a wide spectrum of clinical disease severity in humans. The novel …

Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge

M Bellan, D Soddu, PE Balbo, A Baricich… - JAMA network …, 2021 - jamanetwork.com
Importance Although plenty of data exist regarding clinical manifestations, course, case
fatality rate, and risk factors associated with mortality in severe coronavirus disease 2019 …

[HTML][HTML] Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

SL Harrison, E Fazio-Eynullayeva, DA Lane… - PLoS …, 2020 - journals.plos.org
Background At the beginning of June 2020, there were nearly 7 million reported cases of
coronavirus disease 2019 (COVID-19) worldwide and over 400,000 deaths in people with …

Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA

… Franssen Casper FM Hemmelder Marc H … - Nephrology Dialysis …, 2021 - academic.oup.com
Diabetes, hypertension and cardiovascular disease have been listed as risk factors for
severe coronavirus disease 2019 (COVID-19) since the first report of the disease in January …

The role of biomarkers in diagnosis of COVID-19–A systematic review

M Kermali, RK Khalsa, K Pillai, Z Ismail, A Harky - Life sciences, 2020 - Elsevier
Aims As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries
and affected over three million confirmed people. We review different biomarkers to evaluate …

[HTML][HTML] Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

A Izcovich, MA Ragusa, F Tortosa, MA Lavena Marzio… - PloS one, 2020 - journals.plos.org
Background and purpose The objective of our systematic review is to identify prognostic
factors that may be used in decision-making related to the care of patients infected with …

Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms

E Ahmadian, SM Hosseiniyan Khatibi… - Reviews in medical …, 2021 - Wiley Online Library
The novel coronavirus (SARS‐CoV‐2) has turned into a life‐threatening pandemic disease
(Covid‐19). About 5% of patients with Covid‐19 have severe symptoms including septic …

[HTML][HTML] Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence

C Sardu, J Gambardella, MB Morelli, X Wang… - Journal of clinical …, 2020 - mdpi.com
The symptoms most commonly reported by patients affected by coronavirus disease (COVID-
19) include cough, fever, and shortness of breath. However, other major events usually …

[HTML][HTML] The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis

K Rahmani, R Shavaleh, M Forouhi… - Frontiers in public …, 2022 - frontiersin.org
Background Vaccination, one of the most important and effective ways of preventing
infectious diseases, has recently been used to control the COVID-19 pandemic. The present …